This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Intermediate-acting insulin

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • basal insulins
    • intermediate-acting insulin
      • onset of action of approximately 1–2 hours
      • maximal effects between 4 and 12 hours
      • usually needs to be injected once or twice a day e.g. isophane insulin (Neutral Protamine Hagedorn [NPH]), such as Human Insulatard® Humulin I®, (also porcine and bovine equivalents)
      • isophane insulin - forms insoluble crystals and injected as a suspension when administered via subcutaneous injection
    • long-acting insulin analogues
      • can last for a longer period than intermediate acting insulins e.g. glargine Lantus® (has a peakless action profile; injected daily), detemir Levemir® (maximal effects after 6–8 hours; injected daily or twice a day)

Reference:

  1. MeReC Bulletin 2007;17(4).

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.